Sleep and Alzheimer’s disease
This scholarship aims to support a PhD candidate to investigate the impact of sleep, sleep-related neuropeptides and other biochemical measures on Alzheimer’s disease pathology.
This project aims to examine the impact of sleep on the pathology of Alzheimer’s disease. As such, measures of sleep, sleep-related neuropeptides and other biochemical measures will be examined to further investigate the mechanisms in which sleep may contribute to Alzheimer’s disease pathology.
Key details
- 20257456
- PhD
- Applications close on 1 July 2025
- Domestic
- Medicine and health
- $38,500 p.a.
About the scholarship
Alzheimer’s disease is a neurodegenerative disease hallmarked by accumulation of β-amyloid and tau proteins in the brain. Evidence has shown that sleep plays a key role in removing toxins from the brain, including β-amyloid and tau.
Therefore, dysregulation of sleep and sleep disturbances can impair the clearance of these toxins that contribute to increased risk of Alzheimer’s disease. However, the mechanisms by which sleep disturbances contribute to Alzheimer’s pathology have not yet been fully elucidated.
To undertake this project, we are looking for an enthusiastic PhD candidate with a keen interest or experience in clinical research and biochemical laboratory analysis. Background in biomedical science or health sciences is preferred.
Availability
This scholarship is available to eligible candidates to undertake a direct entry three-year PhD program.
Components
The scholarship comprises:
- a tuition fee offset/scholarship
- a living allowance stipend.
The value of each stipend scholarship is $38,500 per annum (full time, indexed) for three years.
How to apply
To apply, send a targeted cover letter and up to date CV to shaun.eslick@mq.edu.au.